MeSH D015473 - promyelocytic leukemia acute
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Tretinoin | Tretinoin | 1998-06-19 | |||
| Arsenic trioxide | Trisenox | 2002-03-05 | ||||
| Padagis | Tretinoin | Tretinoin | 1998-12-24 | |||
| Taro Pharmaceutical | Tretinoin | Tretinoin | 2019-01-25 | |||
| Glenmark Pharmaceuticals | Tretinoin | Tretinoin | 2016-12-23 | |||
| Ingenus | Arsenic trioxide | Arsenic Trioxide | 2018-11-15 | |||
| Mylan | Arsenic trioxide | Arsenic trioxide Mylan | 2020-04-01 | |||
| Tretinoin | Avita | 1998-01-29 | ||||
| Tretinoin | Tretinoin | 2013-07-17 | ||||
| Almirall | Tretinoin, Mequinol | Solage | 1999-12-10 | |||
| Clindamycin, Tretinoin | Veltin | 2010-07-16 | ||||
| Sandoz | Arsenic trioxide | Arsenic Trioxide | 2021-12-02 | |||
| Bausch Health Companies | Tretinoin | Renova | 1995-12-29 | |||
| Tretinoin | Retin-a | 1982-01-01 | ||||
| Clindamycin, Tretinoin | Ziana | 2006-11-07 | ||||
| Allergan | Tretinoin | Tretinoin | 2010-03-22 | |||
| Clindamycin, Tretinoin | Clindamycin Tretinoin | 2015-06-12 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
61%14/23
Phase 2
15%6/41
Phase 3
67%8/12
Approved: 2Overall Success rate: 6%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use